Table 1 Patients’ characteristics

Age, mean ± SD years, (n)

Gender, n (%)

Female

:

1424

(54.1 %)

Male

:

1100

(41.8 %)

Non-response

:

106

(4.0 %)

Employment status, n (%)

Employed

:

186

(7.1 %)

Helping with the housework

:

288

(11.0 %)

Unemployed

:

2095

(79.7 %)

Non-response

:

61

(2.3 %)

Necessity of caregiving, n (%)

Not requiring caregiving

:

981

(37.3 %)

Requiring partial caregiving

:

1317

(50.1 %)

Requiring total caregiving

:

286

(10.9 %)

Non-response

:

46

(1.7 %)

Type of institutions which the patients attend for treatment, n (%) -multiple answers allowed-

University hospital

:

581

(22.1 %)

Hospital except for university hospitals

:

1475

(56.1 %)

Clinic

:

572

(21.7 %)

Not attending any medical institutions

:

24

(0.9 %)

Others

:

137

(5.2 %)

Non-response

:

34

(1.3 %)

Duration of Parkinson’s disease, n (%)

<3 years

:

221

(8.4 %)

3-7 years

:

681

(25.9 %)

≥7 years

:

1675

(63.7 %)

Unknown

:

53

(2.0 %)

Hoehn and Yahr stage, n (%)

Stage I

:

76

(2.9 %)

Stage II

:

207

(7.9 %)

Stage III

:

959

(36.5 %)

Stage IV

:

322

(12.2 %)

Stage V

:

92

(3.5 %)

Unknown

:

974

(37.0 %)

Officially acknowledged patient with the specific disease, n (%)

Yes

:

2157

(82.0 %)

No

:

380

(14.4 %)

Non-response

:

93

(3.5 %)

Anti-parkinsonian medication, n (%) -multiple answers allowed-

Levodopa

:

1667

(63.4 %)

Pramipexole IR

:

1076

(40.9 %)

Pramipexole ER

:

215

(8.2 %)

Ropinirole

:

474

(18.0 %)

Cabergoline

:

294

(11.2 %)

Pergolide

:

294

(11.2 %)

Bromocriptine

:

58

(2.2 %)

Entacapone

:

945

(35.9 %)

Selegiline

:

918

(34.9 %)

Zonisamide

:

460

(17.5 %)

Others

:

1427

(54.3 %)

Non-response

:

166

(6.3 %)